Lazertinib (Synonyms: YH25448; GNS-1480)
目录号: PL01737 纯度: ≥99%
CAS No. :1903008-80-9
商品编号 规格 价格 会员价 是否有货 数量
PL01737-5mg 5mg ¥1697.50 请登录
PL01737-10mg 10mg ¥2537.50 请登录
PL01737-50mg 50mg ¥8400.00 请登录
PL01737-100mg 100mg ¥12697.00 请登录
PL01737-200mg 200mg 询价 询价
PL01737-500mg 500mg 询价 询价
PL01737-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2156.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Lazertinib
英文名称
Lazertinib
英文别名
Lazertinib;YH25448;GNS1480;4A2Y23XK11;N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide;N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide;N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide;Lazertinib [USAN];Lazertinib [I;Leclaza;Lazertinib [INN];Lazertinib (YH25448);GTPL10136;BCP30440;BDBM50555575
Cas No.
1903008-80-9
分子式
C30H34N8O3
分子量
554.64
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Lazertinib (YH25448) 是一种有效,可逆,可口服,可透过血脑屏障的,突变体选择性的第三代 EGFR 酪氨酸激酶抑制剂,可用于非小细胞肺癌的研究。
生物活性
Lazertinib (YH25448) is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor, and can be used in the research of non-small cell lung cancer.
性状
Solid
IC50 & Target[1][2]
EGFR
体外研究(In Vitro)
Lazertinib (YH25448) is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor, and can be used in the research of non-small cell lung cancer. Lazertinib targets both T790M mutation and activating EGFR mutations (EGFRm) while sparing wild type. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Byoung Chul Cho, et al. YH25448, a 3rd Generation EGFR-TKI, in Patients with EGFR-TKI-resistant NSCLC: Phase I/II Study Results.
溶解度数据
In Vitro: DMSO : 9 mg/mL (16.23 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2